LumaBridge
Research ServicesUnited States51-200 Employees
LumaBridge (formerly Cancer Insight) is an oncology-focused CRO, designing and executing innovative clinical trial solutions for emerging biopharma companies.
Leadership Modernization The recent promotion of Todd Lehman to CEO and strategic hires like Amanda Ferrier as COO highlight LumaBridge's focus on leadership stability and operational excellence, signaling a company open to innovative growth initiatives and strategic partnerships.
Oncology Expertise Specializing in oncology-focused clinical research and forming alliances such as the partnership with Parker Institute for Cancer Immunotherapy, LumaBridge is well-positioned as a go-to partner for emerging biopharma companies developing innovative cancer therapies.
Growth Potential With a revenue range of $10M to $25M and recent leadership enhancements, LumaBridge shows strong revenue stability and expansion prospects, making it an attractive target for service providers offering advanced clinical trial solutions.
Technology Stack Utilizing cloud-based technologies like AWS and Cloudflare, LumaBridge demonstrates a commitment to leveraging modern infrastructure for scalable and secure data management, indicating openness to innovative tech partnerships to optimize clinical trials.
Market Focus Targeting emerging biotech firms and early-stage biopharma companies in the oncology space, LumaBridge presents significant opportunities for sales teams to offer specialized CRO services, including trial design, execution, and data management tailored to innovative cancer therapies.
LumaBridge uses 8 technology products and services including Amazon Web Services, Cloudflare, MySQL, and more. Explore LumaBridge's tech stack below.
| LumaBridge Email Formats | Percentage |
| FLast@cancerinsight.com | 76% |
| LFirst@cancerinsight.com | 13% |
| Last@cancerinsight.com | 5% |
| First.Last@cancerinsight.com | 3% |
| First_L@cancerinsight.com | 3% |
| FLast@lumabridge.com | 100% |
Research ServicesUnited States51-200 Employees
LumaBridge (formerly Cancer Insight) is an oncology-focused CRO, designing and executing innovative clinical trial solutions for emerging biopharma companies.
LumaBridge's revenue is estimated to be in the range of $10M$25M
LumaBridge's revenue is estimated to be in the range of $10M$25M